{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:56:46Z","timestamp":1790125006973,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["135827"],"award-info":[{"award-number":["135827"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["166565"],"award-info":[{"award-number":["166565"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K23HL166770"],"award-info":[{"award-number":["K23HL166770"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Belfer Endowment"},{"DOI":"10.13039\/100000967","name":"American Health Assistance Foundation","doi-asserted-by":"publisher","award":["23POST1026402"],"award-info":[{"award-number":["23POST1026402"]}],"id":[{"id":"10.13039\/100000967","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI156274"],"award-info":[{"award-number":["R01AI156274"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["135827"],"award-info":[{"award-number":["135827"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["166565"],"award-info":[{"award-number":["166565"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["K23HL166770"],"award-info":[{"award-number":["K23HL166770"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI156274"],"award-info":[{"award-number":["R01AI156274"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) with preserved ejection fraction (HFpEF) reflects half of all clinical HF yet has few therapies. Obesity and diabetes are now common comorbidities which have focused attention towards underlying myocardial metabolic defects. The profile of a major metabolic pathway, glycolytic intermediates and their regulating enzymes and ancillary pathways, remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Endomyocardial biopsies from HFpEF (n\u2009=\u200937) and non-failing controls (n\u2009=\u200921) were assayed by non-targeted or targeted metabolomics and immunoblot to determine glycolytic and ancillary pathway metabolites and protein expression of their regulating enzymes. Glucose and GLUT1 expression were higher in HFpEF, but prominent glycolytic metabolites: glucose-6-phosphate, fructose-1,6-biphosphate (F1,6bP), and 3-phosphoglycerate were reduced by \u221278%, \u221291%, and \u221273%, respectively, versus controls. Expression of their corresponding synthesizing enzymes hexokinase, phospho-fructokinase, and phosphoglycerate kinase were also significantly lower (all p\u2009&amp;lt;\u20090.0005). Pentose phosphate and hexosamine biosynthetic pathway metabolites were reduced while glycogen content increased. Despite proximal reduction in key glycolytic intermediates, pyruvate increased but mitochondrial pyruvate transporter (MPC1) expression was reduced. Pyruvate dehydrogenase converting pyruvate to acetyl-CoA was more activated but some Krebs cycle intermediates were reduced. This HFpEF glycolytic profile persisted after adjusting for body mass index (BMI), diabetes, age, and sex, or in subgroup analysis with controls and HFpEF matched for BMI and diabetes\/insulin history. In HFpEF, BMI but not glycated haemoglobin negatively correlated with F1,6bP (p\u2009=\u20097e-5, r\u2009=\u2009\u22120.61) and phosphoenolpyruvate (p\u2009=\u20090.006, r\u2009=\u2009\u22120.46).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Human HFpEF myocardium exhibits reduced glycolytic and ancillary pathway intermediates and expression of their synthesizing proteins. This combines features reported in HF with reduced ejection fraction and obesity\/diabetes that likely exacerbate metabolic inflexibility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3389","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:39:34Z","timestamp":1723189174000},"page":"1941-1951","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Landscape of Glycolytic Metabolites and Their Regulating Proteins in Myocardium from Human Heart Failure with Preserved Ejection Fraction"],"prefix":"10.1093","volume":"26","author":[{"given":"Navid","family":"Koleini","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Meddeb","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, and Department of Oncology, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]},{"name":"Complete Omics Inc , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Keykhaei","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung","family":"Kwon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Farshidfar","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia S.","family":"Hahn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika L.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, and Department of Oncology, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kass","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]},{"name":"Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"2026010913051846400_ejhf3389-bib-0001","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026010913051846400_ejhf3389-bib-0002","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026010913051846400_ejhf3389-bib-0003","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026010913051846400_ejhf3389-bib-0004","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.122.059785","article-title":"Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes","volume":"146","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"key":"2026010913051846400_ejhf3389-bib-0005","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"2026010913051846400_ejhf3389-bib-0006","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"2026010913051846400_ejhf3389-bib-0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.123.001791","article-title":"Obesity is a major determinant of impaired cardiac energy metabolism in heart failure with preserved ejection fraction","volume":"388","author":"G\u00fcven","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"2026010913051846400_ejhf3389-bib-0008","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacbts.2016.06.009","article-title":"Evidence of glycolysis up-regulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: Implications for cardiac reloading and conditioning","volume":"1","author":"Diakos","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"2026010913051846400_ejhf3389-bib-0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026010913051846400_ejhf3389-bib-0010","doi-asserted-by":"crossref","first-page":"H422","DOI":"10.1152\/ajpheart.00219.2020","article-title":"In vivo [U-13C]glucose labeling to assess heart metabolism in murine models of pressure and volume overload","volume":"319","author":"Schnelle","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026010913051846400_ejhf3389-bib-0011","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"key":"2026010913051846400_ejhf3389-bib-0012","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"2026010913051846400_ejhf3389-bib-0013","first-page":"817","article-title":"Integrated landscape of cardiac metabolism in end-stage human nonischemic dilated cardiomyopathy","volume":"1","author":"Flam","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"2026010913051846400_ejhf3389-bib-0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10020-018-0005-x","article-title":"Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction","volume":"24","author":"Fillmore","year":"2018","journal-title":"Mol Med"},{"key":"2026010913051846400_ejhf3389-bib-0015","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","article-title":"Heart failure and diabetes: Metabolic alterations and therapeutic interventions: A state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology","volume":"39","author":"Maack","year":"2018","journal-title":"Eur Heart J"},{"key":"2026010913051846400_ejhf3389-bib-0016","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCULATIONAHA.119.044452","article-title":"The role of nonglycolytic glucose metabolism in myocardial recovery upon mechanical unloading and circulatory support in chronic heart failure","volume":"142","author":"Badolia","year":"2020","journal-title":"Circulation"},{"key":"2026010913051846400_ejhf3389-bib-0017","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/emmm.201200240","article-title":"Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production","volume":"4","author":"Wu","year":"2012","journal-title":"EMBO Mol Med"},{"key":"2026010913051846400_ejhf3389-bib-0018","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15742","article-title":"Impaired cardiac glycolysis and glycogen depletion are linked to poor myocardial outcomes in juvenile male swine with metabolic syndrome and ischemia","volume":"11","author":"Broadwin","year":"2023","journal-title":"Physiol Rep"},{"key":"2026010913051846400_ejhf3389-bib-0019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacbts.2023.11.006","article-title":"Cardiac substrate utilization and relationship to invasive exercise hemodynamic parameters in HFpEF","volume":"9","author":"O'Sullivan","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"2026010913051846400_ejhf3389-bib-0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","article-title":"Myocardial gene expression signatures in human heart failure with preserved ejection fraction","volume":"143","author":"Hahn","year":"2021","journal-title":"Circulation"},{"key":"2026010913051846400_ejhf3389-bib-0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2017.41.1.1","article-title":"My sweetheart is broken: Role of glucose in diabetic cardiomyopathy","volume":"41","author":"Brahma","year":"2017","journal-title":"Diabetes Metab J"},{"key":"2026010913051846400_ejhf3389-bib-0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00639","article-title":"Metabolic profiling of the diabetic heart: Toward a richer picture","volume":"10","author":"Sowton","year":"2019","journal-title":"Front Physiol"},{"key":"2026010913051846400_ejhf3389-bib-0023","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s42255-020-00288-1","article-title":"Mitochondrial pyruvate carriers are required for myocardial stress adaptation","volume":"2","author":"Zhang","year":"2020","journal-title":"Nat Metab"},{"key":"2026010913051846400_ejhf3389-bib-0024","doi-asserted-by":"crossref","DOI":"10.1038\/s44161-024-00516-x","article-title":"Myocardial ultrastructure of human heart failure with preserved ejection fraction","author":"Meddeb","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"2026010913051846400_ejhf3389-bib-0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiolgenomics.00016.2011","article-title":"Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure","volume":"44","author":"Lunde","year":"2012","journal-title":"Physiol Genomics"},{"key":"2026010913051846400_ejhf3389-bib-0026","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1074\/jbc.M707328200","article-title":"Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase","volume":"283","author":"Taylor","year":"2008","journal-title":"J Biol Chem"},{"key":"2026010913051846400_ejhf3389-bib-0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","article-title":"Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis","volume":"126","author":"Ritterhoff","year":"2020","journal-title":"Circ Res"},{"key":"2026010913051846400_ejhf3389-bib-0028","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCRESAHA.119.316260","article-title":"Noninvasive in vivo assessment of cardiac metabolism in the healthy and diabetic human heart using hyperpolarized 13C MRI","volume":"126","author":"Rider","year":"2020","journal-title":"Circ Res"},{"key":"2026010913051846400_ejhf3389-bib-0029","article-title":"Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026010913051846400_ejhf3389-bib-0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.122.061688","article-title":"Sodium glucose cotransporter-2 inhibitor empagliflozin reduces infarct size independently of sodium glucose cotransporter-2","volume":"147","author":"Chen","year":"2023","journal-title":"Circulation"},{"key":"2026010913051846400_ejhf3389-bib-0031","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s42255-019-0115-y","article-title":"Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation","volume":"1","author":"Martin","year":"2019","journal-title":"Nat Metab"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/9\/1941\/65511459\/eurjhf_26_9_1941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/9\/1941\/65511459\/eurjhf_26_9_1941.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:06:14Z","timestamp":1767981974000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/26\/9\/1941\/8328671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,8,9]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3389","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"2024-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}